Renal tubulointerstitial changes after internal irradiation with α-particle-emitting actinium daughters

被引:73
作者
Jaggi, JS
Seshan, SV
McDevitt, MR
LaPerle, K
Sgouros, G
Scheinberg, DA
机构
[1] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA
[4] Cornell Univ, Weill Med Coll, Res Anim Resource Ctr, New York, NY 10021 USA
[5] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2005年 / 16卷 / 09期
关键词
D O I
10.1681/ASN.2004110945
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The effect of external gamma irradiation on the kidneys is well described. However, the mechanisms of radiation nephropathy as a consequence of targeted radionuclide therapies are poorly understood. The functional and morphologic changes were studied chronologically (from 10 to 40 wk) in mouse kidneys after injection with an actinium-225 (Ac-225) nanogenerator, a molecular-sized, antibody-targeted, in vivo generator of alpha-particle-emitting elements. Renal irradiation from free, radioactive daughters of Ac-225 led to time-dependent reduction in renal function manifesting as increase in blood urea nitrogen. The histopathologic changes corresponded with the decline in renal function. Glomerular, tubular, and endothelial cell nuclear pleomorphism and focal tubular cell injury, lysis, and karyorrhexis were observed as early as 10 wk. Progressive thinning of the cortex as a result of widespread tubulolysis, collapsed tubules, glomerular crowding, decrease in glomerular cellularity, interstitial inflammation, and an elevated juxtaglomerular cell count were noted at 20 to 30 wk after treatment. By 35 to 40 wk, regeneration of simplified tubules with tubular atrophy and loss with focal, mild interstitial fibrosis had occurred. A lower juxtaglomerular cell count with focal cytoplasmic vacuolization, suggesting increased degranulation, was also observed in this period. A focal increase in tubular and interstitial cell TGF-beta(1), expression starting at 20 wk, peaking at 25 wk, and later declining in intensity with mild increase in the extracellular matrix deposition was noticed. These findings suggest that internally delivered alpha-particle irradiation-induced loss of tubular epithelial cells triggers a chain of adaptive changes that result in progressive renal parenchymal damage accompanied by a loss of renal function. These findings are dissimilar to those seen after gamma or beta irradiation of kidneys.
引用
收藏
页码:2677 / 2689
页数:13
相关论文
共 50 条
  • [1] Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations
    Behr, TM
    Goldenberg, DM
    Becker, W
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (02) : 201 - 212
  • [2] Behr TM, 1997, CANCER-AM CANCER SOC, V80, P2591, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2591::AID-CNCR35>3.0.CO
  • [3] 2-5
  • [4] Selective T-cell ablation with bismuth-213-labeled anti-TCRαβ as nonmyeloablative conditioning for allogeneic canine marrow transplantation
    Bethge, WA
    Wilbur, DS
    Storb, R
    Hamlin, DK
    Santos, EB
    Brechbiel, MW
    Fisher, DR
    Sandmaier, BM
    [J]. BLOOD, 2003, 101 (12) : 5068 - 5075
  • [5] Borchardt PE, 2003, CANCER RES, V63, P5084
  • [6] TGF-beta in kidney fibrosis: A target for gene therapy
    Border, WA
    Noble, NA
    [J]. KIDNEY INTERNATIONAL, 1997, 51 (05) : 1388 - 1396
  • [7] Bouchet LG, 2003, J NUCL MED, V44, P1113
  • [8] Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
    Brown, NJ
    Nakamura, S
    Ma, LJ
    Nakamura, I
    Donnert, E
    Freeman, M
    Vaughan, DE
    Fogo, AB
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (03) : 1219 - 1227
  • [9] Brown NJ, 2002, J NEPHROL, V15, P230
  • [10] 188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia
    Bunjes, D
    [J]. LEUKEMIA & LYMPHOMA, 2002, 43 (11) : 2125 - 2131